|
⚲
|
| Keyboard |
| Elite Pharmaceuticals Inc /NV/
✚
|
|
|---|---|
| CIK # | 0001053369 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001053369] | |
| 10-Q | [0001053369] | |
| 3 | [0001053369] | |
| 4 | [0001053369] | |
| 5 | [0001053369] | |
| 8-K | [0001053369] | |
| D | [0001053369] | |
| SC 13D | [0001053369] | |
| SC 13G | [0001053369] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Mikah Pharma LLC | Elite Pharmaceuticals Inc /NV/ | [2014-02-19] |
| [2012-12-14] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Elite Pharmaceuticals Inc /NV/ ELTP
Stock Options (right to buy)
|
2026-01-09 | Option exercise | 2,500,000 | $0.03 | 75,000 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Stock Options (right to buy) · derivative
|
2026-01-09 | Option exercise | 2,500,000 | $0.00 | |
|
Elite Pharmaceuticals Inc /NV/ ELTP
common stock
|
2025-10-02 | Sell | 800,000 | $0.62 | 496,000 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2025-07-10 | Buy | 16,366 | $0.59 | 9,656 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Stock Options (right to buy)
|
2025-07-08 | Sell | 200,000 | $0.58 | 116,000 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Stock Options (right to buy)
|
2025-07-03 | Option exercise | 2,500,000 | $0.03 | 75,000 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Stock Options (right to buy) · derivative
|
2025-07-03 | Option exercise | 2,500,000 | $0.00 | |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2024-10-24 | Sell | 333,932 | $0.51 | 170,305 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2024-10-23 | Sell | 800,000 | $0.49 | 392,000 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2024-03-29 | Grant | 49,534,368 | $0.00 | |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2023-12-29 | Grant | 2,223,147 | $0.07 | 155,620 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2023-11-22 | Grant | 547,657 | $0.04 | 21,906 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2023-11-22 | Grant | 547,657 | $0.04 | 21,906 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2023-11-22 | Grant | 547,657 | $0.04 | 21,906 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Options · derivative
|
2023-01-03 | Grant | 7,500,000 | $0.03 | 225,000 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Options · derivative
|
2022-09-06 | Grant | 3,000,000 | $0.04 | 120,000 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2022-08-28 | Grant | 459,536 | $0.04 | 18,381 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2022-08-28 | Grant | 459,536 | $0.04 | 18,381 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Common Stock
|
2022-08-28 | Grant | 459,536 | $0.04 | 18,381 |
|
Elite Pharmaceuticals Inc /NV/ ELTP
Options · derivative
|
2022-05-16 | Grant | 900,000 | $0.04 | 36,000 |
| showing 20 of 200 most recent transactions | |||||